Michelle A. Ozbun

9.2k citations

47 papers · 2.6k indexed · h-index 31

Epidemiology top 2%
Molecular Biology top 10%
Immunology top 5%
Genetics top 5%
Oncology top 5%

Co-authors: Craig Meyers Samuel K. Campos Zurab Surviladze Jessica L. Smith Rosa T. Sterk Janet S. Butel Lawrence Banks Michael P. Myers
Topics: Cervical Cancer and HPV Research (28 papers)Virus-based gene therapy research (11 papers)Molecular Biology Techniques and Applications (9 papers)
Cited by: Epidemiology Virology Immunology
Journals: Proceedings of the National Academy of Sciences PLoS ONE Cancer Research
Partner nations: United States Italy China

In The Last Decade

Michelle A. Ozbun

47 papers receiving 2.5k citations

Peers

Countries citing papers authored by Michelle A. Ozbun

Since Specialization

Citations

This map shows the geographic impact of Michelle A. Ozbun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Ozbun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Ozbun more than expected).

Fields of papers citing papers by Michelle A. Ozbun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Ozbun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Ozbun. The network helps show where Michelle A. Ozbun may publish in the future.

Co-authorship network of co-authors of Michelle A. Ozbun

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Ozbun. A scholar is included among the top collaborators of Michelle A. Ozbun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Ozbun. Michelle A. Ozbun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis 2023 ·Antiviral Research ·(unknown),(unknown),Rosa T. Sterk,(unknown),(unknown),Donna F. Kusewitt,Huining Kang,Michelle A. Ozbun	2
2	MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors 2021 ·PLoS Pathogens ·(unknown),Rosa T. Sterk,(unknown),Joon‐Yong Chung,Kiersten L. Berggren,(unknown),(unknown),Andrew T. Cowan,Gregory N. Gan,Emrullah Yilmaz,Hanbyoul Cho,Jae‐Hoon Kim,Stephen M. Hewitt,Julie E. Bauman,Michelle A. Ozbun	25
3	The long and winding road: human papillomavirus entry and subcellular trafficking 2021 ·Current Opinion in Virology ·Michelle A. Ozbun,Samuel K. Campos	27
4	Infectious titres of human papillomaviruses (HPVs) in patient lesions, methodological considerations in evaluating HPV infectivity and implications for the efficacy of high-level disinfectants 2021 ·EBioMedicine ·Michelle A. Ozbun,(unknown),(unknown),Rosa T. Sterk,Alan G. Waxman,(unknown),Rohini McKee,Ankur Sharma,(unknown),Marc Rogers,Gary Eichenbaum	14
5	Extracellular events impacting human papillomavirus infections: Epithelial wounding to cell signaling involved in virus entry 2019 ·Papillomavirus Research ·Michelle A. Ozbun	26
6	The Known and Potential Intersections of Rab-GTPases in Human Papillomavirus Infections 2019 ·Frontiers in Cell and Developmental Biology ·(unknown),(unknown),(unknown),Michelle A. Ozbun	18
7	Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer 2018 ·Cancer Research ·Toni M. Brand,Stefan Hartmann,Neil E. Bhola,Hua Li,Yan Zeng,Rachel A. O’Keefe,Max V. Ranall,Sourav Bandyopadhyay,Margaret Soucheray,Nevan J. Krogan,Carolyn Kemp,Umamaheswar Duvvuri,Theresa LaVallee,Daniel E. Johnson,Michelle A. Ozbun,Julie E. Bauman,Jennifer R. Grandis	31
8	Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR/PI3K/Akt/c-Jun Signaling Pathway in Cervical Cancer Cells 2018 ·Frontiers in Microbiology ·Juan P. Muñoz,(unknown),(unknown),Gloria M. Calaf,Óscar León,Edio Maldonado,Julio C. Tapia,Enrique Boccardo,Michelle A. Ozbun,Francisco Aguayo	40
9	Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting 2017 ·Scientific Reports ·Daniela I. Staquicini,Roberto Rangel,Liliana Guzman‐Rojas,Fernanda I. Staquicini,Andrey S. Dobroff,Christy A. Tarleton,Michelle A. Ozbun,Mikhail G. Kolonin,Juri G. Gelovani,Serena Marchiò,Richard L. Sidman,Katherine A. Hajjar,Wadih Arap,Renata Pasqualini	39
10	Interaction of human papillomavirus type 16 particles with heparan sulfate and syndecan-1 molecules in the keratinocyte extracellular matrix plays an active role in infection 2015 ·Journal of General Virology ·Zurab Surviladze,(unknown),Michelle A. Ozbun	45
11	Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes 2014 ·Carcinogenesis ·Lanlan Wei,(unknown),Ming Chu,Michelle A. Ozbun	36
12	Essential Roles for Soluble Virion-Associated Heparan Sulfonated Proteoglycans and Growth Factors in Human Papillomavirus Infections 2012 ·PLoS Pathogens ·Zurab Surviladze,(unknown),Michelle A. Ozbun	148
13	Nitric Oxide Induces Early Viral Transcription Coincident with Increased DNA Damage and Mutation Rates in Human Papillomavirus–Infected Cells 2009 ·Cancer Research ·Lanlan Wei,Patti E. Gravitt,(unknown),(unknown),Michelle A. Ozbun	79
14	Inducible heat shock protein 70 enhances HPV31 viral genome replication and virion production during the differentiation-dependent life cycle in human keratinocytes 2009 ·Virus Research ·(unknown),Pope Moseley,(unknown),Michelle A. Ozbun	18
15	Virus activated filopodia promote human papillomavirus type 31 uptake from the extracellular matrix 2008 ·Virology ·Jessica L. Smith,Diane S. Lidke,Michelle A. Ozbun	59
16	Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators 2008 ·Oncogene ·Vjekoslav Tomaić,Daniela Gardiol,Paola Massimi,Michelle A. Ozbun,Michael P. Myers,Lawrence Banks	63
17	Using an Immortalized Cell Line to Study the HPV Life Cycle in Organotypic 2005 ·Humana Press eBooks ·Paul F. Lambert,Michelle A. Ozbun,(unknown),(unknown),Denis Lee,Tomomi Nakahara	59
18	Variable expression of some “housekeeping” genes during human keratinocyte differentiation 2002 ·Analytical Biochemistry ·(unknown),Craig Meyers,Michelle A. Ozbun	75
19	Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis 1995 ·Advances in cancer research ·Michelle A. Ozbun,Janet S. Butel	72
20	Glycogen Phosphorylase: Developmental Expression in Rat Liver 1993 ·Neonatology ·C Bloch,Michelle A. Ozbun,SA Khan	3

About Michelle A. Ozbun

Michelle A. Ozbun is a scholar working on Epidemiology, Microbiology and Immunology, having authored 47 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (28 papers), Virus-based gene therapy research (11 papers) and Molecular Biology Techniques and Applications (9 papers). The work is most often cited by research in Epidemiology (1.5k citations), Virology (157 citations) and Immunology (605 citations). Michelle A. Ozbun has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Craig Meyers, Samuel K. Campos, Zurab Surviladze, Jessica L. Smith, Rosa T. Sterk, Janet S. Butel, Lawrence Banks, Michael P. Myers, Paul F. Lambert and Lanlan Wei. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact